FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Johnson David Louis 2. Issuer Name and Ticker or Trading Symbol DYNAVAX TECHNOLOGIES CORP [ DVAX ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Vice President
(Last)         (First)         (Middle)
C/O DYNAVAX TECHNOLOGIES, 2100 POWELL STREET, SUITE 900
3. Date of Earliest Transaction (MM/DD/YYYY)
2/5/2020
(Street)
EMERYVILLE, CA 94608
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  2/5/2020    M    4687  A  (1) 46411  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)  $5.42  2/12/2020    A     31000       (2) 2/11/2027  Common Stock  31000  $0.00  31000  D   
Restricted Stock Unit   (1) 2/5/2020    M     4687       (1)  (1) Common Stock  4687   (1) 0  D   

Explanation of Responses:
(1)  Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock that vested and converted to common stock on February 5, 2020.
(2)  This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date, and one thirty-sixth (1/36) of the shares subject to the option vesting on the last day of each month thereafter.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Johnson David Louis
C/O DYNAVAX TECHNOLOGIES
2100 POWELL STREET, SUITE 900
EMERYVILLE, CA 94608


Vice President

Signatures
/s/ David Johnson 2/14/2020
**Signature of Reporting Person Date
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Oct 2020 to Nov 2020 Click Here for more Dynavax Technologies Charts.
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Nov 2019 to Nov 2020 Click Here for more Dynavax Technologies Charts.